PTS-Benefits Heading


PTS-Benefits 2 boxes

Comply With Plasma Testing Requirements Regulatory agencies require plasma screening for five pathogens—HIV, HBV, HCV, HAV, and Parvo B19—before fractionation. Plasma should also be free of irregular antibodies and have acceptable Anti-A and Anti-B titers to prevent hemolytic events in patients infused with IVIGs.
Enhance Screening Results With Grifols Grifols instruments help plasma-screening laboratories improve safety by detecting and excluding donations containing pathogens and irregular antibodies from entering manufacturing pools. Our products also reduce learning curves and improve efficiency, ensuring reliable results while reducing costs.

PTS-Portfolio Sliders Heading

Plasma Solutions Portfolio

PTS-Portfolio Sliders

PTS-Portfolio CTA

Plasma Solutions Contact CTA

Contact Us to Get Started

Request your virtual meeting with a workflow expert to take advantage of our consulting services.


PTS-Featured Articles Heading

PTS-Featured Articles

PTS-Learn More links

Plasma Testing Solution Disclaimer

This information is intended for physicians and healthcare professionals only.

Product registration and availability vary by country. For more information on product availability, please contact us here.